Formulation of solid nano-sized particles in a gel-forming system
First Claim
Patent Images
1. A method of recording an X-ray image of the body of a mammal, comprising the steps of:
- a. providing a formulation comprising a plurality of solid in-organic particles and an organic gel-forming system, wherein the solid in-organic particles have a (number) average diameter of 1-500 nm and comprise or consist of a compound detectable by X-ray imaging, and the organic gel-forming system undergoes gel-formation when injected into a body of a mammal, the formulation is imagable, the plurality of solid in-organic particles comprise one or more selected from the group consisting of X-ray contrast agents, radioactive compounds, paramagnetic compounds, fluorescent compounds, ferromagnetic compounds and mixtures thereof, and the formulation has a viscosity less than 10,000 centipoise (cP) at 20°
C.;
b. administering the formulation to a predetermined location of the mammal; and
c. recording X-ray-based images of at least a part of the body which comprises the predetermined location.
1 Assignment
0 Petitions
Accused Products
Abstract
The present invention relates to novel formulations comprising a plurality of nano-sized solid particles and a gel-forming system, useful, e.g. for imaging of the body of a mammal. Also described are kits comprising such formulations and imaging methods utilizing such formulations or kits.
24 Citations
9 Claims
-
1. A method of recording an X-ray image of the body of a mammal, comprising the steps of:
-
a. providing a formulation comprising a plurality of solid in-organic particles and an organic gel-forming system, wherein the solid in-organic particles have a (number) average diameter of 1-500 nm and comprise or consist of a compound detectable by X-ray imaging, and the organic gel-forming system undergoes gel-formation when injected into a body of a mammal, the formulation is imagable, the plurality of solid in-organic particles comprise one or more selected from the group consisting of X-ray contrast agents, radioactive compounds, paramagnetic compounds, fluorescent compounds, ferromagnetic compounds and mixtures thereof, and the formulation has a viscosity less than 10,000 centipoise (cP) at 20°
C.;b. administering the formulation to a predetermined location of the mammal; and c. recording X-ray-based images of at least a part of the body which comprises the predetermined location. - View Dependent Claims (2)
-
-
3. A method of joint radiotherapy and X-ray imaging of a target tissue in a mammal, comprising the steps of:
-
a, providing a formulation comprising a plurality of solid in-organic particles and an organic gel-forming system, wherein the solid in-organic particles have a (number) average diameter of 1-500 nm and comprise or consist of a compound detectable by X-ray imaging, the organic gel-forming system undergoes gel-formation when injected into a body of a mammal, the formulation is imagable, the plurality of solid in-organic particles comprise one or more selected from the group consisting of X-ray contrast agents, radioactive compounds, paramagnetic compounds, fluorescent compounds, ferromagnetic compounds and mixtures thereof, and the formulation has a viscosity less than 10,000 centipoise (cP) at 20°
C.;b. administering the formulation to a predetermined target tissue of the mammal; c. recording X-ray-based images of at least a part of the body which comprises the target tissue, thereby providing a definition of the target tissue; and d. using the definition of the target tissue obtained in c. to direct external beam radiotherapy to the target tissue. - View Dependent Claims (4, 5, 6, 7)
-
-
8. A method for directing local administration of a pharmaceutically active agent to a target tissue in a mammal, comprising the steps of:
-
a. providing a formulation comprising a plurality of solid in-organic particles and an organic gel-forming system, wherein the solid in-organic particles have a (number) average diameter of 1-500 nm and comprise or consist of a detectable compound;
optionally detectable by X-ray imaging, the organic gel-forming system undergoes gel-formation when injected into the body of a mammal, the formulation is imagable;
the plurality of solid in-organic particles comprise one or more selected from the group consisting of X-ray contrast agents, radioactive compounds, paramagnetic compounds, fluorescent compounds, ferromagnetic compounds, and mixtures thereof, and the formulation has a viscosity less than 10,000 centipoise (cP) at 20°
C.;b. administering the formulation to a predetermined target tissue of the mammal; c. recording images of at least a part of the body which comprises the target tissue, thereby providing a definition of the target tissue; and d. using the definition of the target tissue obtained in step c. to direct local administration of a pharmaceutically active agent to the target tissue. - View Dependent Claims (9)
-
Specification